New Perspectives for Patients with Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type

Chemotherapy. 2024;69(3):165-167. doi: 10.1159/000535734. Epub 2023 Dec 8.

Authors

Emanuele Cencini¹, Alberto Fabbri¹, Elisa Cinotti², Pietro Rubegni², Monica Bocchia¹

Affiliations

¹ Unit of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy.
² Department of Medical, Surgical and Neurological Science, Dermatology Section, University of Siena, Siena, Italy.

PMID: 38071958
DOI: 10.1159/000535734

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Humans
Leg* / pathology
Lymphoma, Large B-Cell, Diffuse* / diagnosis
Lymphoma, Large B-Cell, Diffuse* / drug therapy
Lymphoma, Large B-Cell, Diffuse* / pathology
Skin Neoplasms* / diagnosis
Skin Neoplasms* / pathology